KATRINA SAMBORSKI: Open Payments
NPI 1710767355 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,202 in 112 payments from 16 companies in 2025. Trend: 2023 $360 · 2024 $2,214 · 2025 $2,202
Food & beverage: $2,202
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $452 |
| Axsome Therapeutics, Inc. | 11 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $282 |
| Neurocrine BioSciences, Inc. | 19 | $269 |
| Janssen Pharmaceuticals, Inc | 10 | $201 |
| ABBVIE INC. | 15 | $198 |
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| Alkermes, Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
Products named: COBENFY, Auvelity, CAPLYTA, INGREZZA, VRAYLAR, SPRAVATO, REXULTI, FANAPT.
Industry payments across VA — which companies pay providers there.
